Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

DMAADrugs Made In America Acquisition Corp.

Nasdaq · CIK 0002028614
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC6770 Blank Checks
FY end1231
XBRL facts96

Identity from submissions API

NameDrugs Made In America Acquisition Corp.
CIK0002028614
TickersDMAA, DMAAR, DMAAU
ExchangesNasdaq, Nasdaq, Nasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC6770 Blank Checks
EIN000000000
LEI—
Fiscal year end1231
State of incorporation—
Phone646-726-7074
Website—
Investor website—
Owner org05 Real Estate & Construction
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
420 LEXINGTON AVENUE
SUITE 1402
NEW YORK
NY
10170
NY
Mailing address
420 LEXINGTON AVENUE
SUITE 1402
NEW YORK
NY
10170
NY

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

81 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 10-Q FORM 10-Q 0001477932-26-007043 001-42467 261560513 34 4668011 1 1
2026-10-21 425 CURRENT REPORT 0001213900-26-111424 001-42467 261476782 34 65333
2026-10-21 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-26-111421 001-42467 261476664 34 304959 1 1
2026-09-14 425 CURRENT REPORT 0001213900-26-099743 001-42467 261377761 34 269408
2026-09-14 8-K CURRENT REPORT 1.01,9.01 0001213900-26-099738 001-42467 261377737 34 551720 1 1
2026-08-14 10-Q QUARTERLY REPORT 0001213900-26-090035 001-42467 261281315 34 4701514 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001072613-26-000664 005-94909 261280870 34 7828
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001604488-26-000087 005-94909 261278294 34 17060
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001076809-26-000079 005-94909 261274864 34 9222
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-095396 005-94909 261269885 34 34000
2026-07-20 425 CURRENT REPORT 0001213900-26-079686 001-42467 261187408 34 90608
2026-07-20 8-K CURRENT REPORT 1.01,9.01 0001213900-26-079678 001-42467 261187363 34 339199 1 1
2026-06-26 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001376474-26-000460 005-94909 261123906 34 13208
2026-05-14 10-Q QUARTERLY REPORT 0001213900-26-056798 001-42467 26980270 34 4251741 1 1
2026-05-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-060643 005-94909 26975738 34 33149
2026-05-05 425 CURRENT REPORT 0001213900-26-052331 001-42467 26944567 34 273191
2026-05-05 8-K CURRENT REPORT 1.01,9.01 0001213900-26-052324 001-42467 26944533 34 541057 1 1
2026-05-01 8-K CURRENT REPORT 5.03,5.07,8.01,9.01 0001213900-26-051018 001-42467 26933668 34 269131 1 1
2026-04-28 8-K CURRENT REPORT 1.01,9.01 0001213900-26-048585 001-42467 26908375 34 293447 1 1
2026-04-16 DEFR14A REVISED DEFINITIVE PROXY STATEMENT 0001213900-26-044631 001-42467 26867514 34 15235
2026-04-15 10-K ANNUAL REPORT 0001213900-26-044139 001-42467 26864890 34 4620759 1 1
2026-04-14 DEF 14A PROXY STATEMENT 0001213900-26-043527 001-42467 26860887 34 3990595
2026-04-08 8-K CURRENT REPORT 8.01,9.01 0001213900-26-041284 001-42467 26846647 34 290284 1 1
2026-04-01 NT 10-K NOTIFICATION OF LATE FILING 0001213900-26-038499 001-42467 26828104 34 21482
2026-03-27 PRE 14A PROXY STATEMENT 0001213900-26-035624 001-42467 26808276 34 380223
2026-03-27 8-K CURRENT REPORT 1.01,2.03,8.01,9.01 0001213900-26-035502 001-42467 26807323 34 296419 1 1
2026-03-06 8-K CURRENT REPORT 8.01 0001213900-26-024762 001-42467 26732035 34 251375 1 1
2026-03-06 8-K CURRENT REPORT 5.02 0001213900-26-024392 001-42467 26728995 34 257773 1 1
2025-11-18 10-Q QUARTERLY REPORT 0001213900-25-112096 001-42467 251494631 34 4554110 1 1
2025-11-18 8-K CURRENT REPORT 5.02 0001213900-25-111704 001-42467 251492591 34 265889 1 1
2025-11-17 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-25-111208 001-42467 251489124 34 22962
2025-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001393825-25-000076 005-94909 251472228 34 10230
2025-08-14 10-Q QUARTERLY REPORT 0001213900-25-076681 001-42467 251219433 34 3890602 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001072613-25-000596 005-94909 251218757 34 7699
2025-05-20 10-Q QUARTERLY REPORT 0001213900-25-046061 001-42467 25970137 34 3533026 1 1
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001604488-25-000134 005-94909 25955914 34 16595
2025-05-15 NT 10-Q NOTIFICATION OF LATE FILING 0001213900-25-044303 001-42467 25954532 34 23822
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001076809-25-000052 005-94909 25953549 34 9000
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001326389-25-000192 005-94909 25948666 34 6686
2025-05-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001072613-25-000381 005-94909 25945218 34 7577
2025-05-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001393825-25-000017 005-94909 25944286 34 11121
2025-03-31 10-K ANNUAL REPORT 0001213900-25-026240 001-42467 25793175 34 3180267 1 1
2025-03-03 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-019525 005-94909 25700611 34 24941
2025-02-25 8-K CURRENT REPORT 3.02,8.01,9.01 0001213900-25-016702 001-42467 25658748 34 80516
2025-02-24 8-K CURRENT REPORT 8.01,9.01 0001213900-25-016602 001-42467 25656852 34 27756
2025-02-18 4 xslF345X05/ownership.xml 0001213900-25-015020 7497
2025-02-18 4 xslF345X05/ownership.xml 0001213900-25-015019 7975
2025-02-04 4 xslF345X05/ownership.xml 0001213900-25-010195 10971
2025-02-04 4 xslF345X05/ownership.xml 0001213900-25-010193 11752
2025-02-04 8-K CURRENT REPORT 8.01,9.01 0001213900-25-010079 001-42467 25588360 34 172137
2025-02-03 4 xslF345X05/ownership.xml 0001213900-25-009602 4772
2025-02-03 4 xslF345X05/ownership.xml 0001213900-25-009600 4771
2025-02-03 4 xslF345X05/ownership.xml 0001213900-25-009597 4755
2025-02-03 4 xslF345X05/ownership.xml 0001213900-25-009595 4818
2025-01-30 8-K CURRENT REPORT 1.01,3.02,5.03,8.01,9.01 0001213900-25-008377 001-42467 25573828 34 1163745
2025-01-29 424B4 PROSPECTUS 0001213900-25-007724 333-281170 25567221 33 4477139
2025-01-27 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000196 333-281170 25560758 33 1702
2025-01-23 CORRESP filename1.htm 0001213900-25-005828 8067
2025-01-23 CORRESP filename1.htm 0001213900-25-005825 11067
2025-01-22 POS AM REGISTRATION STATEMENT 0001213900-25-005176 333-281170 25543837 33 4673200
2025-01-14 POS AM POST-EFFECTIVE AMENDMENT 0001213900-25-003137 333-281170 25527716 33 4674581
2025-01-10 3 xslF345X02/ownership.xml 0001213900-25-002358 2873
2025-01-10 3 xslF345X02/ownership.xml 0001213900-25-002356 2888
2025-01-10 3 xslF345X02/ownership.xml 0001213900-25-002353 3664
2025-01-10 3 xslF345X02/ownership.xml 0001213900-25-002351 4251
2025-01-10 3 xslF345X02/ownership.xml 0001213900-25-002349 2890
2025-01-10 3 xslF345X02/ownership.xml 0001213900-25-002347 2934
2025-01-08 CERT 8A_Cert_DMAA.pdf 0001354457-25-000013 001-42467 25516676 34 218599
2025-01-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000044 333-281170 25516410 33 1689
2025-01-07 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-25-001726 001-42467 25515907 34 25790
2025-01-06 S-1/A REGISTRATION STATEMENT 0001213900-25-001208 333-281170 25512041 33 145132
2025-01-03 CORRESP filename1.htm 0001213900-25-000704 10123
2025-01-03 CORRESP filename1.htm 0001213900-25-000703 11083
2024-12-09 S-1/A REGISTRATION STATEMENT 0001213900-24-106894 333-281170 241534905 33 4592376
2024-11-25 S-1/A REGISTRATION STATEMENT 0001213900-24-102238 333-281170 241496752 33 4834151
2024-11-07 S-1/A AMENDMENT NO. 3 TO FORM S-1 0001213900-24-095138 333-281170 241432995 33 5152175
2024-09-27 S-1/A REGISTRATION STATEMENT 0001213900-24-082386 333-281170 241330448 33 5604695
2024-09-06 CORRESP filename1.htm 0001213900-24-076551 45333
2024-09-06 S-1/A REGISTRATION STATEMENT 0001213900-24-076546 333-281170 241284877 33 4368071
2024-08-27 UPLOAD filename1.pdf 0000000000-24-009773 333-281170 48429
2024-08-01 S-1 REGISTRATION STATEMENT 0001213900-24-064074 333-281170 241166509 33 4888840

Latest XBRL company facts

One latest value per concept from companyfacts (96 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 24.28M 2026-11-16 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
dei EntityPublicFloat Entity Public Float USD 234.60M 2025-06-30 2025 FY 10-K 2026-04-15 0001213900-26-044139
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 254,908 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 302,623 2025-09-30 2025 Q3 10-Q 2025-11-18 0001213900-25-112096
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 3.42M 2025-01-01 2025-03-31 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 147,830 2025-01-01 2025-03-31 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap AdministrativeFeesExpense Administrative Fees Expense USD 81,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-18 0001213900-25-112096
us-gaap Assets Assets USD 147.46M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap AssetsCurrent Assets, Current USD 48,991 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap AssetsHeldInTrust Assets Held-in-trust USD 99.31M 2026-04-27 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 147.41M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap AssetsNoncurrent Assets, Noncurrent USD 147.41M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap Cash Cash USD 17,011 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 20,280 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 17,011 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 10,874 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 6,137 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044139
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 220.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 10.72M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 10.72M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,072 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 6.90M 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044139
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 350,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 6.19M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 545,833 2024-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044139
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 848,201 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026240
us-gaap Deposits Deposits USD 300,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.03 2024-05-23 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026240
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.03 2024-05-23 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026240
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 375,925 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -42,276 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 77,280 2024-05-23 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026240
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 42,850 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 25,925 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 5.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 2.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044139
us-gaap Liabilities Liabilities USD 8.45M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 147.46M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.26M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 6.19M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap LoansPayable Loans Payable USD 1.10M 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044139
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -97.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 97.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -414,126 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 4.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 5.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap NotesIssued1 Notes Issued USD 204,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap NotesPayableCurrent Notes Payable, Current USD 350,000 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap NumberOfOperatingSegments Number of Operating Segments integer 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -375,925 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap OtherCommitment Other Commitment USD 500,000 2026-03-23 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap OtherNotesPayable Other Notes Payable USD 1.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap OtherUnderwritingExpense Other Underwriting Expense USD 6.90M 2024-05-23 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026240
us-gaap PaymentsForRepurchaseOfOtherEquity Payments for Repurchase of Other Equity USD 99.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap PaymentsForUnderwritingExpense Payments for Underwriting Expense USD 1.15M 2024-05-23 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026240
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 363,599 2024-05-23 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026240
us-gaap PaymentsToAcquireTrustPreferredInvestments Payments to Acquire Trust Preferred Investments USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 1.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 31,980 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap ProceedsFromContributionsFromAffiliates Proceeds from Contributions from Affiliates USD 1.35M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044139
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 350,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap ProceedsFromOtherShortTermDebt Proceeds from Other Short-term Debt USD 1.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 425,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 4.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 325,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044139
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -8.40M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 430,000 2025-01-01 2025-03-31 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 10.05 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 10.52 2026-04-27 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares shares 13.56M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -8.40M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap StockholdersEquityNoteSubscriptionsReceivable Stockholders' Equity Note, Subscriptions Receivable USD 608,822 2025-09-30 2025 Q3 10-Q 2025-11-18 0001213900-25-112096
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 200,000 2025-03-01 2025-03-11 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 230,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 45,092 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 2.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044139
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 3.20M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 3.20M 2025-01-01 2025-03-31 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap StockRedeemedOrCalledDuringPeriodValue Stock Redeemed or Called During Period, Value USD 147,830 2025-01-01 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044139
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 2.46M 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001213900-26-090035
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 147.41M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 10.43 2025-12-31 2025 FY 10-K 2026-04-15 0001213900-26-044139
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 10.87 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 13.56M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001477932-26-007043
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 8.57M 2024-05-23 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026240
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 8.57M 2024-05-23 2024-12-31 2024 FY 10-K 2025-03-31 0001213900-25-026240

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →